Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2011-08-30 17:40 |
VIVALIS PUBLISHES ITS FIRST HALF RESULTS AND CONFIRMS ITS TARGETS FOR 2011
|
English | 268.0 KB | ||
| 2011-08-30 17:40 |
VIVALIS publie ses résultats pour le 1er semestre et confirme ses objectifs 2011
|
French | 272.4 KB | ||
| 2011-08-12 08:30 |
VIVALIS Actions et droits de vote
|
English | 51.8 KB | ||
| 2011-07-21 17:40 |
VIVALIS : Poursuite d'une forte dynamique de croissance au 1er semestre 2011
|
French | 93.6 KB | ||
| 2011-07-21 17:40 |
VIVALIS : Sustained momentum drives strong growth in the 2011 first-half
|
English | 240.6 KB | ||
| 2011-07-12 17:40 |
TRANSGENE AND VIVALIS ENTER INTO A COMMERCIAL LICENSE AND COLLABORATION AGREEME…
|
English | 105.0 KB | ||
| 2011-07-12 17:40 |
TRANSGENE ET VIVALIS SIGNENT UN ACCORD DE LICENCE COMMERCIALE ET DE COLLABORATI…
|
French | 96.9 KB | ||
| 2011-07-07 20:18 |
VIVALIS ACTIONS ET DROITS DE VOTE JUIN 2011
|
English | 51.4 KB | ||
| 2011-06-21 17:40 |
VIVALIS SIGNS A NEW COMMERCIAL LICENSE FOR THE EB66® CELL LINE WITH KYOTO BIKE…
|
English | 97.8 KB | ||
| 2011-06-21 17:40 |
VIVALIS SIGNE UNE NOUVELLE LICENCE COMMERCIALE DE LA LIGNEE CELLULAIRE EB66® A…
|
French | 83.3 KB | ||
| 2011-06-08 17:40 |
VIVALIS ACTIONS ET DROITS DE VOTE
|
English | 51.2 KB | ||
| 2011-05-04 17:40 |
VIVALIS REPORTS FIRST QUARTER REVENUES
|
English | 106.9 KB | ||
| 2011-05-04 17:40 |
VIVALIS PUBLIE SON CHIFFRE D'AFFAIRES DU 1ER TRIMESTRE
|
French | 111.4 KB | ||
| 2011-05-02 17:50 |
VIVALIS : MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES A l'AGM
|
English | 225.7 KB | ||
| 2011-05-02 17:45 |
VIVALIS ACTIONS ET DROITS DE VOTE
|
English | 50.8 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
